AMS, A., AM, M., MA, T., M, A., AMI, A., & AR, A. (2026). Pharmacogenomic and inflammatory determinants of antipsychotic-induced extrapyramidal toxicity in Egyptian patients with schizophrenia. Expert opinion on drug metabolism & toxicology, 22(3), 233. https://doi.org/10.1080/17425255.2026.2660702
Chicago Style (17th ed.) CitationAMS, Ahmed, Moawad AM, Tarek MA, Abdelgwad M, Aboutaleb AMI, and Abouelkheir AR. "Pharmacogenomic and Inflammatory Determinants of Antipsychotic-induced Extrapyramidal Toxicity in Egyptian Patients with Schizophrenia." Expert Opinion on Drug Metabolism & Toxicology 22, no. 3 (2026): 233. https://doi.org/10.1080/17425255.2026.2660702.
MLA (9th ed.) CitationAMS, Ahmed, et al. "Pharmacogenomic and Inflammatory Determinants of Antipsychotic-induced Extrapyramidal Toxicity in Egyptian Patients with Schizophrenia." Expert Opinion on Drug Metabolism & Toxicology, vol. 22, no. 3, 2026, p. 233, https://doi.org/10.1080/17425255.2026.2660702.